Ultrasound of the abdomen shows coarse hepatic echotexture consistent with liver disease; what further imaging should be performed?

Further Imaging After Coarse Hepatic Echotexture on Ultrasound

For patients with coarse hepatic echotexture on ultrasound suggesting chronic liver disease, proceed with either ultrasound shear wave elastography (US SWE) or MR elastography to stage liver fibrosis, as these are the most appropriate initial diagnostic imaging modalities 1.

Primary Recommendation: Elastography for Fibrosis Staging

The ACR Appropriateness Criteria explicitly designates US shear wave elastography or MR elastography as "usually appropriate" for initial imaging to diagnose and stage liver fibrosis in chronic liver disease patients 1. These are considered equivalent alternatives—you only need to order one procedure 1.

Why Elastography?

• MR elastography is currently the most accurate imaging modality for diagnosis and staging of hepatic fibrosis 1
• It outperforms US shear wave elastography, particularly in patients with obesity 1
• Conventional imaging (CT, standard MRI, or US) has insufficient sensitivity for detecting early-stage fibrosis because they rely on gross structural changes that only appear in advanced disease 1

Choosing Between US SWE vs MR Elastography

Select MR elastography if:

• Patient has obesity (better performance than US SWE) 1
• You need the highest diagnostic accuracy
• Resources are available

Select US shear wave elastography if:

• Patient has hepatic iron deposition (MR elastography has limitations here) 1
• Cost or access is a barrier
• Faster turnaround is needed

Important caveat: MR elastography can be confounded by parenchymal edema, inflammation, cholestasis, cardiogenic hepatic congestion, or recent meals 1. US SWE has similar confounders.

Secondary Consideration: HCC Surveillance

If fibrosis staging confirms cirrhosis or advanced fibrosis, immediately initiate hepatocellular carcinoma (HCC) surveillance with one of these equivalent options 1:

• US abdomen every 6 months
• MRI abdomen without and with IV contrast
• MRI abdomen without and with hepatobiliary contrast

These are the "usually appropriate" modalities for HCC screening in chronic liver disease patients 1.

What NOT to Do

• Do not order contrast-enhanced CT or conventional MRI as the next step for fibrosis assessment—they detect only advanced structural changes and miss early fibrosis 1
• Do not rely on morphologic features alone (surface nodularity, caudate hypertrophy, right lobe atrophy)—sensitivity is too low to exclude hepatic fibrosis 1
• The ACR panel specifically noted insufficient evidence to recommend CT abdomen with IV contrast for HCC screening 1

Clinical Algorithm

1. Coarse echotexture on US → Order elastography (US SWE or MR elastography)
2. If significant fibrosis/cirrhosis confirmed → Initiate HCC surveillance (US or MRI every 6 months)
3. If no significant fibrosis → Address underlying liver disease etiology, repeat elastography as clinically indicated

This approach prioritizes accurate fibrosis staging to guide prognosis and management, while avoiding unnecessary radiation exposure and contrast administration in patients who may not need it 2.